UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell

Nature communications, 2021-03, Vol.12 (1), p.1716-1716, Article 1716

2021

Volltextzugriff (PDF)

Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11624

2023

Volltextzugriff (PDF)

Cerebrospinal fluid levels of orexin-A, histamine and sleep profile within the Alzheimer process

Neurobiology of aging, 2017-05, Vol.53, p.59-66

2017

Volltextzugriff (PDF)

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification

Alzheimer's research & therapy, 2020-03, Vol.12 (1), p.26-11, Article 26

2020

Volltextzugriff (PDF)

Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity

Scientific reports, 2020-07, Vol.10 (1), p.10923-10923, Article 10923

2020

Volltextzugriff (PDF)

Readthrough isoform of aquaporin-4 (AQP4) as a therapeutic target for Alzheimer's disease and other proteinopathies

Alzheimer's research & therapy, 2023-10, Vol.15 (1), p.170-170, Article 170

2023

Volltextzugriff (PDF)

Peripheral Blood and Salivary Biomarkers of Blood-Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts

Frontiers in neurology, 2021-02, Vol.11, p.577312-577312

2021

Volltextzugriff (PDF)

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid

Scientific reports, 2016-05, Vol.6 (1), p.25162-25162, Article 25162

2016

Volltextzugriff (PDF)

Hypoxemia increases blood-brain barrier permeability during extreme apnea in humans

Journal of cerebral blood flow and metabolism, 2022-06, Vol.42 (6), p.1120-1135

2022

Volltextzugriff (PDF)

Inherited mitochondrial dysfunction triggered by OPA1 mutation impacts the sensory innervation fibre identity, functionality and regenerative potential in the cornea

Scientific reports, 2024-08, Vol.14 (1), p.18794-16, Article 18794

2024

Volltextzugriff (PDF)

Exocytosis and protein secretion in Trypanosoma

BMC microbiology, 2010-01, Vol.10 (1), p.20-20

2010

Volltextzugriff (PDF)

The alternative proteome in neurobiology

Frontiers in cellular neuroscience, 2022-11, Vol.16, p.1019680

2022

Volltextzugriff (PDF)

Hepcidin and ferritin levels in restless legs syndrome: a case–control study

Scientific reports, 2020-07, Vol.10 (1), p.11914-11914, Article 11914

2020

Volltextzugriff (PDF)

Increasing the sensitivity of Simoa via bead count reduction facilitates the quantification of pTau‐181 in dried plasma spots

Alzheimer's & dementia : translational research & clinical interventions, 2024-01, Vol.10 (1), p.e12456-n/a

2024

Volltextzugriff (PDF)

Tau protein in cerebrospinal fluid: a novel biomarker of the time of death?

International journal of legal medicine, 2021-09, Vol.135 (5), p.2081-2089

2021

Volltextzugriff (PDF)

β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease

Alzheimer's research & therapy, 2022-11, Vol.14 (1), p.179-179, Article 179

2022

Volltextzugriff (PDF)

Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease

Molecular neurodegeneration, 2024-10, Vol.19 (1), p.66-14, Article 66

2024

Volltextzugriff (PDF)

SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases

Nature reviews. Neurology, 2019-07, Vol.15 (7), p.419-427

2019

Volltextzugriff (PDF)

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

BMC cancer, 2019-01, Vol.19 (1), p.110-110, Article 110

2019

Volltextzugriff (PDF)

Cytokines as new biomarkers of skin wound vitality

International journal of legal medicine, 2021-11, Vol.135 (6), p.2537-2545

2021

Volltextzugriff (PDF)

A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration

International journal of molecular sciences, 2022-06, Vol.23 (13), p.7221

2022

Volltextzugriff (PDF)

Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases

Frontiers in aging neuroscience, 2020-11, Vol.12, p.232-232

2020

Volltextzugriff (PDF)

Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson's Disease

Frontiers in aging neuroscience, 2022-03, Vol.14, p.818606-818606

2022

Volltextzugriff (PDF)

New Perspectives of Multiplex Mass Spectrometry Blood Protein Quantification on Microsamples in Biological Monitoring of Elderly Patients

International journal of molecular sciences, 2023-04, Vol.24 (8), p.6989

2023

Volltextzugriff (PDF)

Gravitational Transitions Increase Posterior Cerebral Perfusion and Systemic Oxidative-nitrosative Stress: Implications for Neurovascular Unit Integrity

Neuroscience, 2020-08, Vol.441, p.142-160

2020

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell

Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges

Cerebrospinal fluid levels of orexin-A, histamine and sleep profile within the Alzheimer process

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification

Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity

Readthrough isoform of aquaporin-4 (AQP4) as a therapeutic target for Alzheimer's disease and other proteinopathies

Peripheral Blood and Salivary Biomarkers of Blood-Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid

Hypoxemia increases blood-brain barrier permeability during extreme apnea in humans

Inherited mitochondrial dysfunction triggered by OPA1 mutation impacts the sensory innervation fibre identity, functionality and regenerative potential in the cornea

Exocytosis and protein secretion in Trypanosoma

The alternative proteome in neurobiology

Hepcidin and ferritin levels in restless legs syndrome: a case–control study

Increasing the sensitivity of Simoa via bead count reduction facilitates the quantification of pTau‐181 in dried plasma spots

Tau protein in cerebrospinal fluid: a novel biomarker of the time of death?

β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease

Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease

SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

Cytokines as new biomarkers of skin wound vitality

A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration

Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases

Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson's Disease

New Perspectives of Multiplex Mass Spectrometry Blood Protein Quantification on Microsamples in Biological Monitoring of Elderly Patients

Gravitational Transitions Increase Posterior Cerebral Perfusion and Systemic Oxidative-nitrosative Stress: Implications for Neurovascular Unit Integrity

Suchergebnisse filtern